Global Molecular Residual Disease Detection Market Growth (Status and Outlook) 2025-2031--LP INFORMATION, INC.

Global Molecular Residual Disease Detection Market Growth (Status and Outlook) 2025-2031

Product Code: 1480397

Industry: Medical Care

Published: Apr 10,2025

Pages: 105

Delivery Time: 2-3 business days

Global Molecular Residual Disease Detection Market Growth (Status and Outlook) 2025-2031

Product Code: 1480397

Industry: Medical Care

Published: Apr 10,2025

Pages: 105

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Molecular Residual Disease Detection market size is predicted to grow from US$ 6876 million in 2025 to US$ 16910 million in 2031; it is expected to grow at a CAGR of 16.2% from 2025 to 2031.

Molecular residual lesions often refer to minimal residual lesions, which refer to a small number of cancer cells that remain in the body after cancer treatment (cancer cells that do not respond to treatment or are drug-resistant).

United States market for Molecular Residual Disease Detection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Molecular Residual Disease Detection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Molecular Residual Disease Detection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Molecular Residual Disease Detection players cover Adaptive, Guardant Health, Invitae, Cergentis B.V, LexentBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Molecular Residual Disease Detection Industry Forecast” looks at past sales and reviews total world Molecular Residual Disease Detection sales in 2024, providing a comprehensive analysis by region and market sector of projected Molecular Residual Disease Detection sales for 2025 through 2031. With Molecular Residual Disease Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Residual Disease Detection industry.

This Insight Report provides a comprehensive analysis of the global Molecular Residual Disease Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Molecular Residual Disease Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Residual Disease Detection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Residual Disease Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Residual Disease Detection.

This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Residual Disease Detection market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Tumor-informed Assays

    Tumor-agnostic Assays

Segmentation by Application:

    Prognosis

    Adjuvant Treatment Decision-Making

    Surveillance for Postoperative Recurrence

    Other

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Adaptive

    Guardant Health

    Invitae

    Cergentis B.V

    LexentBio

    Natera

BGI

    Zhiben Medical

    Burning Rock Medicine

    Huidu Medical

    Zhenhe Technology

    ExactSciences

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Molecular Residual Disease Detection Market Size (2020-2031)
        2.1.2 Molecular Residual Disease Detection Market Size CAGR by Region (2020 VS 2024 VS 2031)
        2.1.3 World Current & Future Analysis for Molecular Residual Disease Detection by Country/Region (2020, 2024 & 2031)
    2.2 Molecular Residual Disease Detection Segment by Type
        2.2.1 Tumor-informed Assays
        2.2.2 Tumor-agnostic Assays
    2.3 Molecular Residual Disease Detection Market Size by Type
        2.3.1 Molecular Residual Disease Detection Market Size CAGR by Type (2020 VS 2024 VS 2031)
        2.3.2 Global Molecular Residual Disease Detection Market Size Market Share by Type (2020-2025)
    2.4 Molecular Residual Disease Detection Segment by Application
        2.4.1 Prognosis
        2.4.2 Adjuvant Treatment Decision-Making
        2.4.3 Surveillance for Postoperative Recurrence
        2.4.4 Other
    2.5 Molecular Residual Disease Detection Market Size by Application
        2.5.1 Molecular Residual Disease Detection Market Size CAGR by Application (2020 VS 2024 VS 2031)
        2.5.2 Global Molecular Residual Disease Detection Market Size Market Share by Application (2020-2025)

3 Molecular Residual Disease Detection Market Size by Player
    3.1 Molecular Residual Disease Detection Market Size Market Share by Player
        3.1.1 Global Molecular Residual Disease Detection Revenue by Player (2020-2025)
        3.1.2 Global Molecular Residual Disease Detection Revenue Market Share by Player (2020-2025)
    3.2 Global Molecular Residual Disease Detection Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Molecular Residual Disease Detection by Region
    4.1 Molecular Residual Disease Detection Market Size by Region (2020-2025)
    4.2 Global Molecular Residual Disease Detection Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Molecular Residual Disease Detection Market Size Growth (2020-2025)
    4.4 APAC Molecular Residual Disease Detection Market Size Growth (2020-2025)
    4.5 Europe Molecular Residual Disease Detection Market Size Growth (2020-2025)
    4.6 Middle East & Africa Molecular Residual Disease Detection Market Size Growth (2020-2025)

5 Americas
    5.1 Americas Molecular Residual Disease Detection Market Size by Country (2020-2025)
    5.2 Americas Molecular Residual Disease Detection Market Size by Type (2020-2025)
    5.3 Americas Molecular Residual Disease Detection Market Size by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Molecular Residual Disease Detection Market Size by Region (2020-2025)
    6.2 APAC Molecular Residual Disease Detection Market Size by Type (2020-2025)
    6.3 APAC Molecular Residual Disease Detection Market Size by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Molecular Residual Disease Detection Market Size by Country (2020-2025)
    7.2 Europe Molecular Residual Disease Detection Market Size by Type (2020-2025)
    7.3 Europe Molecular Residual Disease Detection Market Size by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Molecular Residual Disease Detection by Region (2020-2025)
    8.2 Middle East & Africa Molecular Residual Disease Detection Market Size by Type (2020-2025)
    8.3 Middle East & Africa Molecular Residual Disease Detection Market Size by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Molecular Residual Disease Detection Market Forecast
    10.1 Global Molecular Residual Disease Detection Forecast by Region (2026-2031)
        10.1.1 Global Molecular Residual Disease Detection Forecast by Region (2026-2031)
        10.1.2 Americas Molecular Residual Disease Detection Forecast
        10.1.3 APAC Molecular Residual Disease Detection Forecast
        10.1.4 Europe Molecular Residual Disease Detection Forecast
        10.1.5 Middle East & Africa Molecular Residual Disease Detection Forecast
    10.2 Americas Molecular Residual Disease Detection Forecast by Country (2026-2031)
        10.2.1 United States Market Molecular Residual Disease Detection Forecast
        10.2.2 Canada Market Molecular Residual Disease Detection Forecast
        10.2.3 Mexico Market Molecular Residual Disease Detection Forecast
        10.2.4 Brazil Market Molecular Residual Disease Detection Forecast
    10.3 APAC Molecular Residual Disease Detection Forecast by Region (2026-2031)
        10.3.1 China Molecular Residual Disease Detection Market Forecast
        10.3.2 Japan Market Molecular Residual Disease Detection Forecast
        10.3.3 Korea Market Molecular Residual Disease Detection Forecast
        10.3.4 Southeast Asia Market Molecular Residual Disease Detection Forecast
        10.3.5 India Market Molecular Residual Disease Detection Forecast
        10.3.6 Australia Market Molecular Residual Disease Detection Forecast
    10.4 Europe Molecular Residual Disease Detection Forecast by Country (2026-2031)
        10.4.1 Germany Market Molecular Residual Disease Detection Forecast
        10.4.2 France Market Molecular Residual Disease Detection Forecast
        10.4.3 UK Market Molecular Residual Disease Detection Forecast
        10.4.4 Italy Market Molecular Residual Disease Detection Forecast
        10.4.5 Russia Market Molecular Residual Disease Detection Forecast
    10.5 Middle East & Africa Molecular Residual Disease Detection Forecast by Region (2026-2031)
        10.5.1 Egypt Market Molecular Residual Disease Detection Forecast
        10.5.2 South Africa Market Molecular Residual Disease Detection Forecast
        10.5.3 Israel Market Molecular Residual Disease Detection Forecast
        10.5.4 Turkey Market Molecular Residual Disease Detection Forecast
    10.6 Global Molecular Residual Disease Detection Forecast by Type (2026-2031)
    10.7 Global Molecular Residual Disease Detection Forecast by Application (2026-2031)
        10.7.1 GCC Countries Market Molecular Residual Disease Detection Forecast

11 Key Players Analysis
    11.1 Adaptive
        11.1.1 Adaptive Company Information
        11.1.2 Adaptive Molecular Residual Disease Detection Product Offered
        11.1.3 Adaptive Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2020-2025)
        11.1.4 Adaptive Main Business Overview
        11.1.5 Adaptive Latest Developments
    11.2 Guardant Health
        11.2.1 Guardant Health Company Information
        11.2.2 Guardant Health Molecular Residual Disease Detection Product Offered
        11.2.3 Guardant Health Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2020-2025)
        11.2.4 Guardant Health Main Business Overview
        11.2.5 Guardant Health Latest Developments
    11.3 Invitae
        11.3.1 Invitae Company Information
        11.3.2 Invitae Molecular Residual Disease Detection Product Offered
        11.3.3 Invitae Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2020-2025)
        11.3.4 Invitae Main Business Overview
        11.3.5 Invitae Latest Developments
    11.4 Cergentis B.V
        11.4.1 Cergentis B.V Company Information
        11.4.2 Cergentis B.V Molecular Residual Disease Detection Product Offered
        11.4.3 Cergentis B.V Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2020-2025)
        11.4.4 Cergentis B.V Main Business Overview
        11.4.5 Cergentis B.V Latest Developments
    11.5 LexentBio
        11.5.1 LexentBio Company Information
        11.5.2 LexentBio Molecular Residual Disease Detection Product Offered
        11.5.3 LexentBio Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2020-2025)
        11.5.4 LexentBio Main Business Overview
        11.5.5 LexentBio Latest Developments
    11.6 Natera
        11.6.1 Natera Company Information
        11.6.2 Natera Molecular Residual Disease Detection Product Offered
        11.6.3 Natera Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2020-2025)
        11.6.4 Natera Main Business Overview
        11.6.5 Natera Latest Developments
    11.7 BGI
        11.7.1 BGI Company Information
        11.7.2 BGI Molecular Residual Disease Detection Product Offered
        11.7.3 BGI Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2020-2025)
        11.7.4 BGI Main Business Overview
        11.7.5 BGI Latest Developments
    11.8 Zhiben Medical
        11.8.1 Zhiben Medical Company Information
        11.8.2 Zhiben Medical Molecular Residual Disease Detection Product Offered
        11.8.3 Zhiben Medical Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2020-2025)
        11.8.4 Zhiben Medical Main Business Overview
        11.8.5 Zhiben Medical Latest Developments
    11.9 Burning Rock Medicine
        11.9.1 Burning Rock Medicine Company Information
        11.9.2 Burning Rock Medicine Molecular Residual Disease Detection Product Offered
        11.9.3 Burning Rock Medicine Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2020-2025)
        11.9.4 Burning Rock Medicine Main Business Overview
        11.9.5 Burning Rock Medicine Latest Developments
    11.10 Huidu Medical
        11.10.1 Huidu Medical Company Information
        11.10.2 Huidu Medical Molecular Residual Disease Detection Product Offered
        11.10.3 Huidu Medical Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2020-2025)
        11.10.4 Huidu Medical Main Business Overview
        11.10.5 Huidu Medical Latest Developments
    11.11 Zhenhe Technology
        11.11.1 Zhenhe Technology Company Information
        11.11.2 Zhenhe Technology Molecular Residual Disease Detection Product Offered
        11.11.3 Zhenhe Technology Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2020-2025)
        11.11.4 Zhenhe Technology Main Business Overview
        11.11.5 Zhenhe Technology Latest Developments
    11.12 ExactSciences
        11.12.1 ExactSciences Company Information
        11.12.2 ExactSciences Molecular Residual Disease Detection Product Offered
        11.12.3 ExactSciences Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2020-2025)
        11.12.4 ExactSciences Main Business Overview
        11.12.5 ExactSciences Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Molecular Residual Disease Detection Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
 Table 2. Molecular Residual Disease Detection Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Tumor-informed Assays
 Table 4. Major Players of Tumor-agnostic Assays
 Table 5. Molecular Residual Disease Detection Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
 Table 6. Global Molecular Residual Disease Detection Market Size by Type (2020-2025) & ($ millions)
 Table 7. Global Molecular Residual Disease Detection Market Size Market Share by Type (2020-2025)
 Table 8. Molecular Residual Disease Detection Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
 Table 9. Global Molecular Residual Disease Detection Market Size by Application (2020-2025) & ($ millions)
 Table 10. Global Molecular Residual Disease Detection Market Size Market Share by Application (2020-2025)
 Table 11. Global Molecular Residual Disease Detection Revenue by Player (2020-2025) & ($ millions)
 Table 12. Global Molecular Residual Disease Detection Revenue Market Share by Player (2020-2025)
 Table 13. Molecular Residual Disease Detection Key Players Head office and Products Offered
 Table 14. Molecular Residual Disease Detection Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 15. New Products and Potential Entrants
 Table 16. Mergers & Acquisitions, Expansion
 Table 17. Global Molecular Residual Disease Detection Market Size by Region (2020-2025) & ($ millions)
 Table 18. Global Molecular Residual Disease Detection Market Size Market Share by Region (2020-2025)
 Table 19. Global Molecular Residual Disease Detection Revenue by Country/Region (2020-2025) & ($ millions)
 Table 20. Global Molecular Residual Disease Detection Revenue Market Share by Country/Region (2020-2025)
 Table 21. Americas Molecular Residual Disease Detection Market Size by Country (2020-2025) & ($ millions)
 Table 22. Americas Molecular Residual Disease Detection Market Size Market Share by Country (2020-2025)
 Table 23. Americas Molecular Residual Disease Detection Market Size by Type (2020-2025) & ($ millions)
 Table 24. Americas Molecular Residual Disease Detection Market Size Market Share by Type (2020-2025)
 Table 25. Americas Molecular Residual Disease Detection Market Size by Application (2020-2025) & ($ millions)
 Table 26. Americas Molecular Residual Disease Detection Market Size Market Share by Application (2020-2025)
 Table 27. APAC Molecular Residual Disease Detection Market Size by Region (2020-2025) & ($ millions)
 Table 28. APAC Molecular Residual Disease Detection Market Size Market Share by Region (2020-2025)
 Table 29. APAC Molecular Residual Disease Detection Market Size by Type (2020-2025) & ($ millions)
 Table 30. APAC Molecular Residual Disease Detection Market Size by Application (2020-2025) & ($ millions)
 Table 31. Europe Molecular Residual Disease Detection Market Size by Country (2020-2025) & ($ millions)
 Table 32. Europe Molecular Residual Disease Detection Market Size Market Share by Country (2020-2025)
 Table 33. Europe Molecular Residual Disease Detection Market Size by Type (2020-2025) & ($ millions)
 Table 34. Europe Molecular Residual Disease Detection Market Size by Application (2020-2025) & ($ millions)
 Table 35. Middle East & Africa Molecular Residual Disease Detection Market Size by Region (2020-2025) & ($ millions)
 Table 36. Middle East & Africa Molecular Residual Disease Detection Market Size by Type (2020-2025) & ($ millions)
 Table 37. Middle East & Africa Molecular Residual Disease Detection Market Size by Application (2020-2025) & ($ millions)
 Table 38. Key Market Drivers & Growth Opportunities of Molecular Residual Disease Detection
 Table 39. Key Market Challenges & Risks of Molecular Residual Disease Detection
 Table 40. Key Industry Trends of Molecular Residual Disease Detection
 Table 41. Global Molecular Residual Disease Detection Market Size Forecast by Region (2026-2031) & ($ millions)
 Table 42. Global Molecular Residual Disease Detection Market Size Market Share Forecast by Region (2026-2031)
 Table 43. Global Molecular Residual Disease Detection Market Size Forecast by Type (2026-2031) & ($ millions)
 Table 44. Global Molecular Residual Disease Detection Market Size Forecast by Application (2026-2031) & ($ millions)
 Table 45. Adaptive Details, Company Type, Molecular Residual Disease Detection Area Served and Its Competitors
 Table 46. Adaptive Molecular Residual Disease Detection Product Offered
 Table 47. Adaptive Molecular Residual Disease Detection Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 48. Adaptive Main Business
 Table 49. Adaptive Latest Developments
 Table 50. Guardant Health Details, Company Type, Molecular Residual Disease Detection Area Served and Its Competitors
 Table 51. Guardant Health Molecular Residual Disease Detection Product Offered
 Table 52. Guardant Health Molecular Residual Disease Detection Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 53. Guardant Health Main Business
 Table 54. Guardant Health Latest Developments
 Table 55. Invitae Details, Company Type, Molecular Residual Disease Detection Area Served and Its Competitors
 Table 56. Invitae Molecular Residual Disease Detection Product Offered
 Table 57. Invitae Molecular Residual Disease Detection Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 58. Invitae Main Business
 Table 59. Invitae Latest Developments
 Table 60. Cergentis B.V Details, Company Type, Molecular Residual Disease Detection Area Served and Its Competitors
 Table 61. Cergentis B.V Molecular Residual Disease Detection Product Offered
 Table 62. Cergentis B.V Molecular Residual Disease Detection Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 63. Cergentis B.V Main Business
 Table 64. Cergentis B.V Latest Developments
 Table 65. LexentBio Details, Company Type, Molecular Residual Disease Detection Area Served and Its Competitors
 Table 66. LexentBio Molecular Residual Disease Detection Product Offered
 Table 67. LexentBio Molecular Residual Disease Detection Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 68. LexentBio Main Business
 Table 69. LexentBio Latest Developments
 Table 70. Natera Details, Company Type, Molecular Residual Disease Detection Area Served and Its Competitors
 Table 71. Natera Molecular Residual Disease Detection Product Offered
 Table 72. Natera Molecular Residual Disease Detection Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 73. Natera Main Business
 Table 74. Natera Latest Developments
 Table 75. BGI Details, Company Type, Molecular Residual Disease Detection Area Served and Its Competitors
 Table 76. BGI Molecular Residual Disease Detection Product Offered
 Table 77. BGI Molecular Residual Disease Detection Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 78. BGI Main Business
 Table 79. BGI Latest Developments
 Table 80. Zhiben Medical Details, Company Type, Molecular Residual Disease Detection Area Served and Its Competitors
 Table 81. Zhiben Medical Molecular Residual Disease Detection Product Offered
 Table 82. Zhiben Medical Molecular Residual Disease Detection Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 83. Zhiben Medical Main Business
 Table 84. Zhiben Medical Latest Developments
 Table 85. Burning Rock Medicine Details, Company Type, Molecular Residual Disease Detection Area Served and Its Competitors
 Table 86. Burning Rock Medicine Molecular Residual Disease Detection Product Offered
 Table 87. Burning Rock Medicine Molecular Residual Disease Detection Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 88. Burning Rock Medicine Main Business
 Table 89. Burning Rock Medicine Latest Developments
 Table 90. Huidu Medical Details, Company Type, Molecular Residual Disease Detection Area Served and Its Competitors
 Table 91. Huidu Medical Molecular Residual Disease Detection Product Offered
 Table 92. Huidu Medical Molecular Residual Disease Detection Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 93. Huidu Medical Main Business
 Table 94. Huidu Medical Latest Developments
 Table 95. Zhenhe Technology Details, Company Type, Molecular Residual Disease Detection Area Served and Its Competitors
 Table 96. Zhenhe Technology Molecular Residual Disease Detection Product Offered
 Table 97. Zhenhe Technology Molecular Residual Disease Detection Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 98. Zhenhe Technology Main Business
 Table 99. Zhenhe Technology Latest Developments
 Table 100. ExactSciences Details, Company Type, Molecular Residual Disease Detection Area Served and Its Competitors
 Table 101. ExactSciences Molecular Residual Disease Detection Product Offered
 Table 102. ExactSciences Molecular Residual Disease Detection Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 103. ExactSciences Main Business
 Table 104. ExactSciences Latest Developments


List of Figures
 Figure 1. Molecular Residual Disease Detection Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Molecular Residual Disease Detection Market Size Growth Rate (2020-2031) ($ millions)
 Figure 6. Molecular Residual Disease Detection Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 7. Molecular Residual Disease Detection Sales Market Share by Country/Region (2024)
 Figure 8. Molecular Residual Disease Detection Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 9. Global Molecular Residual Disease Detection Market Size Market Share by Type in 2024
 Figure 10. Molecular Residual Disease Detection in Prognosis
 Figure 11. Global Molecular Residual Disease Detection Market: Prognosis (2020-2025) & ($ millions)
 Figure 12. Molecular Residual Disease Detection in Adjuvant Treatment Decision-Making
 Figure 13. Global Molecular Residual Disease Detection Market: Adjuvant Treatment Decision-Making (2020-2025) & ($ millions)
 Figure 14. Molecular Residual Disease Detection in Surveillance for Postoperative Recurrence
 Figure 15. Global Molecular Residual Disease Detection Market: Surveillance for Postoperative Recurrence (2020-2025) & ($ millions)
 Figure 16. Molecular Residual Disease Detection in Other
 Figure 17. Global Molecular Residual Disease Detection Market: Other (2020-2025) & ($ millions)
 Figure 18. Global Molecular Residual Disease Detection Market Size Market Share by Application in 2024
 Figure 19. Global Molecular Residual Disease Detection Revenue Market Share by Player in 2024
 Figure 20. Global Molecular Residual Disease Detection Market Size Market Share by Region (2020-2025)
 Figure 21. Americas Molecular Residual Disease Detection Market Size 2020-2025 ($ millions)
 Figure 22. APAC Molecular Residual Disease Detection Market Size 2020-2025 ($ millions)
 Figure 23. Europe Molecular Residual Disease Detection Market Size 2020-2025 ($ millions)
 Figure 24. Middle East & Africa Molecular Residual Disease Detection Market Size 2020-2025 ($ millions)
 Figure 25. Americas Molecular Residual Disease Detection Value Market Share by Country in 2024
 Figure 26. United States Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 27. Canada Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 28. Mexico Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 29. Brazil Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 30. APAC Molecular Residual Disease Detection Market Size Market Share by Region in 2024
 Figure 31. APAC Molecular Residual Disease Detection Market Size Market Share by Type (2020-2025)
 Figure 32. APAC Molecular Residual Disease Detection Market Size Market Share by Application (2020-2025)
 Figure 33. China Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 34. Japan Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 35. South Korea Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 36. Southeast Asia Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 37. India Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 38. Australia Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 39. Europe Molecular Residual Disease Detection Market Size Market Share by Country in 2024
 Figure 40. Europe Molecular Residual Disease Detection Market Size Market Share by Type (2020-2025)
 Figure 41. Europe Molecular Residual Disease Detection Market Size Market Share by Application (2020-2025)
 Figure 42. Germany Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 43. France Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 44. UK Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 45. Italy Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 46. Russia Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 47. Middle East & Africa Molecular Residual Disease Detection Market Size Market Share by Region (2020-2025)
 Figure 48. Middle East & Africa Molecular Residual Disease Detection Market Size Market Share by Type (2020-2025)
 Figure 49. Middle East & Africa Molecular Residual Disease Detection Market Size Market Share by Application (2020-2025)
 Figure 50. Egypt Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 51. South Africa Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 52. Israel Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 53. Turkey Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 54. GCC Countries Molecular Residual Disease Detection Market Size Growth 2020-2025 ($ millions)
 Figure 55. Americas Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 56. APAC Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 57. Europe Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 58. Middle East & Africa Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 59. United States Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 60. Canada Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 61. Mexico Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 62. Brazil Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 63. China Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 64. Japan Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 65. Korea Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 66. Southeast Asia Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 67. India Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 68. Australia Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 69. Germany Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 70. France Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 71. UK Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 72. Italy Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 73. Russia Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 74. Egypt Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 75. South Africa Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 76. Israel Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 77. Turkey Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)
 Figure 78. Global Molecular Residual Disease Detection Market Size Market Share Forecast by Type (2026-2031)
 Figure 79. Global Molecular Residual Disease Detection Market Size Market Share Forecast by Application (2026-2031)
 Figure 80. GCC Countries Molecular Residual Disease Detection Market Size 2026-2031 ($ millions)

Companies Mentioned

Adaptive

Guardant Health

Invitae

Cergentis B.V

LexentBio

Natera

BGI

Zhiben Medical

Burning Rock Medicine

Huidu Medical

Zhenhe Technology

ExactSciences

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff